Home › Psoriasis › Pennsylvania

Pag-aaral pangklinika para sa Psoriasis sa Pennsylvania

6 pag-aaral para sa Psoriasis ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Philadelphia5 pag-aaral

Opisyal na teksto ng pag-aaral (English)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UPMC Hillman Cancer Center, Pittsburgh

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06857942

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Paddington Testing Company, Philadelphia

Nagre-recruitPhase 3

Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06979453

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

LEO Pharma Investigational Site, Philadelphia

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07013201

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Study Center, Philadelphia

Nagre-recruitPhase 2

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07489885

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Temple University, Philadelphia

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 9, 2025 · NCT05642182

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.